These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Antibiotic treatment for Clostridium difficile-associated diarrhea in adults. Nelson R Cochrane Database Syst Rev; 2007 Jul; (3):CD004610. PubMed ID: 17636768 [TBL] [Abstract][Full Text] [Related]
8. Administration of spores of nontoxigenic Clostridium difficile strain M3 for prevention of recurrent C. difficile infection: a randomized clinical trial. Gerding DN; Meyer T; Lee C; Cohen SH; Murthy UK; Poirier A; Van Schooneveld TC; Pardi DS; Ramos A; Barron MA; Chen H; Villano S JAMA; 2015 May; 313(17):1719-27. PubMed ID: 25942722 [TBL] [Abstract][Full Text] [Related]
9. Prevention of beta-lactam-associated diarrhea by Saccharomyces boulardii compared with placebo. McFarland LV; Surawicz CM; Greenberg RN; Elmer GW; Moyer KA; Melcher SA; Bowen KE; Cox JL Am J Gastroenterol; 1995 Mar; 90(3):439-48. PubMed ID: 7872284 [TBL] [Abstract][Full Text] [Related]
10. Breaking the cycle: treatment strategies for 163 cases of recurrent Clostridium difficile disease. McFarland LV; Elmer GW; Surawicz CM Am J Gastroenterol; 2002 Jul; 97(7):1769-75. PubMed ID: 12135033 [TBL] [Abstract][Full Text] [Related]
11. Clostridium difficile infection in older adults: a review and update on its management. Kee VR Am J Geriatr Pharmacother; 2012 Feb; 10(1):14-24. PubMed ID: 22260856 [TBL] [Abstract][Full Text] [Related]
12. Saccharomyces cerevisiae fungemia in an elderly patient with Clostridium difficile colitis. Cherifi S; Robberecht J; Miendje Y Acta Clin Belg; 2004; 59(4):223-4. PubMed ID: 15597730 [TBL] [Abstract][Full Text] [Related]
13. Recurrent Clostridium difficile diarrhea: characteristics of and risk factors for patients enrolled in a prospective, randomized, double-blinded trial. Fekety R; McFarland LV; Surawicz CM; Greenberg RN; Elmer GW; Mulligan ME Clin Infect Dis; 1997 Mar; 24(3):324-33. PubMed ID: 9114180 [TBL] [Abstract][Full Text] [Related]
14. Prevention of further recurrences of Clostridium difficile colitis with Saccharomyces boulardii. Kimmey MB; Elmer GW; Surawicz CM; McFarland LV Dig Dis Sci; 1990 Jul; 35(7):897-901. PubMed ID: 2364845 [TBL] [Abstract][Full Text] [Related]
15. Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea in children: a randomized double-blind placebo-controlled trial. Kotowska M; Albrecht P; Szajewska H Aliment Pharmacol Ther; 2005 Mar; 21(5):583-90. PubMed ID: 15740542 [TBL] [Abstract][Full Text] [Related]
17. A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity. Zar FA; Bakkanagari SR; Moorthi KM; Davis MB Clin Infect Dis; 2007 Aug; 45(3):302-7. PubMed ID: 17599306 [TBL] [Abstract][Full Text] [Related]
18. Predictors of first recurrence in Clostridium difficile-associated disease. A study of 306 patients hospitalized in a Romanian tertiary referral center. Lupse M; Flonta M; Cioara A; Filipescu I; Todor N J Gastrointestin Liver Dis; 2013 Dec; 22(4):397-403. PubMed ID: 24369321 [TBL] [Abstract][Full Text] [Related]
19. Treatment of asymptomatic Clostridium difficile carriers (fecal excretors) with vancomycin or metronidazole. A randomized, placebo-controlled trial. Johnson S; Homann SR; Bettin KM; Quick JN; Clabots CR; Peterson LR; Gerding DN Ann Intern Med; 1992 Aug; 117(4):297-302. PubMed ID: 1322075 [TBL] [Abstract][Full Text] [Related]
20. A retrospective review of metronidazole and vancomycin in the management of Clostridium difficile infection in patients with hematologic malignancies. Parmar SR; Bhatt V; Yang J; Zhang Q; Schuster M J Oncol Pharm Pract; 2014 Jun; 20(3):172-82. PubMed ID: 23804627 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]